Subscribe now

Letter: Why medical psilocybin is vastly expensive

Published 13 September 2017

From Charles Sawyer, Byron Bay, New South Wales, Australia

Graham Lawton mentions that synthesising medical-grade psilocybin is “staggeringly expensive” (19 August, p 42). The significant cost is complying with the regulations for working with a scheduled substance. The very similar synthetic drug sumatriptan is routinely prescribed for migraine relief, and psilocybin is a simpler compound. And can't psilocybin be purified to medical grade from natural sources?

The editor writes:
• Robin Carhart-Harris tells us that only synthetic psilocybin qualifies as medical grade.

Issue no. 3143 published 16 September 2017

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop